90 related articles for article (PubMed ID: 17395294)
1. Strut fracture of DES: an increasing problem?
Jin X; Zhang S; Xie H; Wang C; Fan Z; Zeng Y; Shen Z; Fang Q
Int J Cardiol; 2007 May; 118(2):e54-6. PubMed ID: 17395294
[TBL] [Abstract][Full Text] [Related]
2. A case of paclitaxel-eluting stent fracture after successful recanalization of chronic total occlusion using a retrograde approach.
Kim JH; Jeong MH; Sim DS; Hong YJ; Ahn Y; Kang JC
Int J Cardiol; 2010 Apr; 140(3):e45-8. PubMed ID: 19117623
[TBL] [Abstract][Full Text] [Related]
3. Delayed strut fracture of sirolimus-eluting stent: a significant problem or an occasional observation?
Min PK; Yoon YW; Moon Kwon H
Int J Cardiol; 2006 Jan; 106(3):404-6. PubMed ID: 16337054
[TBL] [Abstract][Full Text] [Related]
4. Multiple stent strut fracture-induced restenosis in a diffuse long lesion treated with overlapping heterogeneous drug-eluting stent.
Kang WC; Moon C; Ahn TH; Shin EK
Int J Cardiol; 2008 Oct; 130(1):e30-3. PubMed ID: 17889952
[TBL] [Abstract][Full Text] [Related]
5. Coronary stent fracture and restenosis in the drug-eluting stent era: do we have clues of management?
Kim EJ; Rha SW; Wani SP; Suh SY; Choi CU; Kim JW; Park CG; Seo HS; Oh DJ
Int J Cardiol; 2007 Sep; 120(3):417-9. PubMed ID: 17084924
[TBL] [Abstract][Full Text] [Related]
6. Treatment of patients with in-stent restenosis.
Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
[TBL] [Abstract][Full Text] [Related]
7. Stent fracture-unusual cause of DES restenosis.
Goyal BK
Catheter Cardiovasc Interv; 2007 Jun; 69(7):993-4. PubMed ID: 17525958
[No Abstract] [Full Text] [Related]
8. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation.
Lee SH; Park JS; Shin DG; Kim YJ; Hong GR; Kim W; Shim BS
Am J Cardiol; 2007 Aug; 100(4):627-30. PubMed ID: 17697818
[TBL] [Abstract][Full Text] [Related]
9. Strut fracture: a further concern with drug-eluting stents.
Pedon L; Zennaro M; Calzolari D; Zanchetta M
J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):949-52. PubMed ID: 18695438
[TBL] [Abstract][Full Text] [Related]
10. Focal in-stent restenosis and in-stent thrombosis within the same bare-metal stent 5 years after deployment in a saphenous vein graft.
Ponnuthurai FA; van Gaal WJ; Channon KM
J Invasive Cardiol; 2007 Dec; 19(12):E369-71. PubMed ID: 18180530
[TBL] [Abstract][Full Text] [Related]
11. The average stent length is longer and the average stent diameter is shorter in patients with drug-eluting stents versus bare-metal stents during percutaneous coronary intervention.
Dilmanian H; Aronow WS; Mundia M; Pucillo AL; Weiss MB; Kalapatapu K; Monsen CE
Am J Ther; 2007; 14(3):277-9. PubMed ID: 17515704
[TBL] [Abstract][Full Text] [Related]
12. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
Zhang F; Qian J; Ge J
J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-eluting balloon: from bench to bed.
De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels.
Quizhpe AR; Feres F; de Ribamar Costa J; Abizaid A; Maldonado G; Costa R; Abizaid A; Cano M; Moreira AC; Staico R; Mattos LA; Tanajura LF; Chaves A; Centemero M; Sousa AM; Sousa JE
Am Heart J; 2007 Aug; 154(2):373-8. PubMed ID: 17643591
[TBL] [Abstract][Full Text] [Related]
15. How to approach drug-eluting stent restenosis.
Roy P; Waksman R
Minerva Cardioangiol; 2006 Oct; 54(5):571-6. PubMed ID: 17019394
[TBL] [Abstract][Full Text] [Related]
16. Understanding the drug-eluting stent trials.
Coolong A; Kuntz RE
Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
[TBL] [Abstract][Full Text] [Related]
17. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents.
Kitoga M; Pasquet A; Preumont V; Kefer J; Hermans MP; Vanoverschelde JL; Buysschaert M
Diabetes Metab; 2008 Feb; 34(1):62-7. PubMed ID: 18069029
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
19. Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing.
Pendyala L; Jabara R; Robinson K; Chronos N
J Interv Cardiol; 2009 Feb; 22(1):37-48. PubMed ID: 19281521
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings.
Aoki J; Kirtane AJ; Dangas GD; Lansky AJ; Morales A; Kimura M; Kim YH; Moussa I; Weisz G; Kreps EM; Collins M; Frankin-Bond T; Stone GW; Moses JW; Leon MB; Mehran R
Am J Cardiol; 2008 Jan; 101(1):58-62. PubMed ID: 18157966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
